Goldenwell Biotech, Inc. reported earnings results for the first quarter ended March 31, 2023. For the first quarter, the company reported sales was USD 0.001422 million compared to USD 0.000397 million a year ago. Net loss was USD 0.033606 million compared to USD 0.03338 million a year ago.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0586 USD | -76.56% | -.--% | -.--% |
1st Jan change | Capi. | |
---|---|---|
-.--% | 5.8M | |
+1.51% | 42.75B | |
+49.22% | 41.61B | |
+8.57% | 41.34B | |
-12.36% | 26.59B | |
+8.92% | 25.49B | |
-25.13% | 18.12B | |
+29.17% | 12.24B | |
-3.12% | 11.76B | |
+6.35% | 11B |
- Stock Market
- Equities
- GWLL Stock
- News Goldenwell Biotech, Inc.
- Goldenwell Biotech, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023